 Continuous-flow left-ventricular assist devices are increasingly used for the treatment of acute or chronic end-stage heart failure Mancini 2015. Three main implantation strategies exist: destination therapy support until end of life, bridge to transplantation support until transplantation, and bridge to candidacy support until transplantation criteria are met. Although LVAD support delivers excellent short-term and long-term results, the current gold standard and last resort of treatment for end-stage heart failure remains orthotopic heart transplantation Lund 2015. 